about
The treatment of systemic lupus proliferative nephritis.Belimumab in the management of systemic lupus erythematosus - an update.Could Lymphocyte Profiling be Useful to Diagnose Systemic Autoimmune Diseases?The pharmacokinetics and safety profiles of belimumab after single subcutaneous and intravenous doses in healthy Japanese volunteers.Unexpected Potency Differences between B-Cell-Activating Factor (BAFF) Antagonist Antibodies against Various Forms of BAFF: Trimer, 60-Mer, and Membrane-Bound.
P2860
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
New treatment options for lupus - a focus on belimumab.
@ast
New treatment options for lupus - a focus on belimumab.
@en
type
label
New treatment options for lupus - a focus on belimumab.
@ast
New treatment options for lupus - a focus on belimumab.
@en
prefLabel
New treatment options for lupus - a focus on belimumab.
@ast
New treatment options for lupus - a focus on belimumab.
@en
P2093
P2860
P356
P1476
New treatment options for lupus - a focus on belimumab
@en
P2093
Albert Darque
Charleric Bornet
Guillemette Thomas
Laurent Chiche
Nathalie Bardin
Noémie Jourde
P2860
P356
10.2147/TCRM.S19819
P577
2012-01-26T00:00:00Z